PRD-004 (PRD Therapeutics)

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NamePRD-004 (PRD Therapeutics)
Drug Alias NamePRD-004 (PRD Therapeutics)PRD-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPRD Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPRD Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDyslipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A